Akram Miramin Mohammadi

Akram Miramin Mohammadi

Auto-generated profile, based on publicly available information

Akram Miramin Mohammadi

Center for Research and Training in Skin Diseases and Leprosy Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in European Cytokine Network
Verified
Journal Article
Closed access
MRMahmoud Nateghi Rostami
Mahmoud Nateghi Rostami
MDMasoumeh Douraghi
Masoumeh Douraghi
AMAkram Miramin Mohammadi
Akram Miramin Mohammadi
BNBahram Nikmanesh
Bahram Nikmanesh
There are reports showing that pro-inflammatory cytokines are dysregulated in patients with Down's syndrome (DS). However, most of these reports concern adults. We analyzed cytokine levels in serum samples from children with DS, and compared them with samples from intellectually disabled (ID), and healthy, control children. Blood samples were collected from 24 DS, 24 age-/sex-matched ID, and 24 age-/sex-matched healthy, control children. Serum levels of the cytokines IL-5, IL-10, IL-13, IFN-γ, and TNF-α were measured using a sandwich ELISA method, . The age range of the children was 1-15 years, with a mean ± SD of 5.75 ± 4.36 years. TNF-α levels were significantly higher in the DS and ID groups compared with those found in healthy, control children (P<0.05). The DS and ID groups had significantly higher IFN-γ levels compared with healthy, control children (P = 0.0002 and P<0.01, respectively), with significant higher levels in the DS than the ID group (P<0.05). Serum from the ID group showed significantly higher IL-10 levels compared with those from the DS group (P<0.05), but not the healthy, control group. Significant correlations were found between the differences in TNF-α and IFN-γ levels, in both ID (rs = 0.558; P = 0.005) and DS children (rs = 0.405; P<0.05). There were no significant differences found in serum levels of IL-13 between the groups, and IL-5 was not detectable in any of the serum samples. Levels of TNF-α and IFN-γ were increased, and IL-10 decreased in serum from children with DS. It may be that these differences contribute to the clinical symptoms seen in DS: consequently, these pro-inflammatory cytokines might be useful as early biomarkers of the disorders associated with DS.

11 July 2008 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
TLT. Lieke
T. Lieke
SNS. Nylén
S. Nylén
LEL. Eidsmo
L. Eidsmo
WMW. R. McMaster
W. R. McMaster
AMA. M. Mohammadi
A. M. Mohammadi
HAH. Akuffo
H. Akuffo
Natural killer (NK) cells contribute to immunity as the first line of defence in numerous infections by early cytokine secretion and cytotoxicity. In Leishmania infection, NK cells contribute with interferon-γ and may assist in directing the immune response towards T helper type 1, which is essential for successful control of the parasites. Thus, NK cells may play an important role in both resistance and control of the infection. However, during Leishmania infection NK cells show signs of suppression. To explore the reason for this suppression, we exposed naive and interleukin (IL)-2 activated NK cells directly to promastigotes of Leishmania major in vitro. As a rapid consequence of contact between naive NK cells and promastigotes, expression of NK cell receptors show significant changes. We identify one of the major surface molecules of promastigotes, glycoprotein (gp) 63, as an important agent for these suppressive effects by using promastigotes of a gp63ko strain of L. major. Furthermore, proliferation of IL-2-activated purified NK cells is suppressed after exposure to the wild-type but not to gp63ko promastigotes. However, gp63ko L. major induced no NK cell proliferation when NK cells were co-cultured with peripheral blood mononuclear cells populations such as CD14+ monocytes or T cells.

11 January 2007 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MKMotahareh Karimzadegan‐Nia
Motahareh Karimzadegan‐Nia
AMAkram Mir‐Amin‐Mohammadi
Akram Mir‐Amin‐Mohammadi
NBNavid Bouzari
Navid Bouzari
AFAlireza Firooz
Alireza Firooz

1 November 2016 in Experimental Parasitology
Verified
Journal Article
Closed access
ASAlireza Sanei-Dehkordi
Alireza Sanei-Dehkordi
AKAli Khamesipour
Ali Khamesipour
KAKamran Akbarzadeh
Kamran Akbarzadeh
AAAmir Ahmad Akhavan
Amir Ahmad Akhavan
AMAkram Mir Amin Mohammadi
Akram Mir Amin Mohammadi
JRJavad Rafinejad
Javad Rafinejad

19 September 2012 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
HVHossein Keshavarz Valian
Hossein Keshavarz Valian
MRMahmoud Nateghi Rostami
Mahmoud Nateghi Rostami
MTMinoo Tasbihi
Minoo Tasbihi
AMAkram Miramin Mohammadi
Akram Miramin Mohammadi
SESeyed Ebrahim Eskandari
Seyed Ebrahim Eskandari
AKAli Khamesipour
Ali Khamesipour

8 August 2018 in Journal of Arthropod-Borne Diseases
Verified
Journal Article
Open access
AKAlireza Khatami
Alireza Khatami
MEMaria Emmelin
Maria Emmelin
RTRezvan Talaee
Rezvan Talaee
AMAkram Miramin-Mohammadi
Akram Miramin-Mohammadi
NANessa Aghazadeh
Nessa Aghazadeh
BSBerndt Stenberg
Berndt Stenberg
Background: The aim of this study was to explore the experiences of patients who suffer from acute cutaneous leishmaniasis in Iran, focusing on quality of life. Methods: The study was conducted at two different sites in Iran in 2010–2011. Individual in-depth interviews were conducted with six men and six women parasitologically confirmed acute cutaneous leishmaniasis. Interviews were recorded, transcribed verbatim, and translated into English. Qualitative content analysis was used for data analysis. Results: The participants, aged 23 to 63yr, had mild to severe disease. Based on the analysis four main themes were developed. "Fearing an agonizing disease" reflects patients' experiences of disease development resulting in sadness and depression, "struggling to cope" and "taking on the blame" both illustrate how patients experience living with the disease, which included both felt and enacted stigma as major social concerns. "Longing for being seen and heard" refers to patients' experiences with healthcare as well as their expectations and demands from communities and healthcare to be involved in closing the knowledge and awareness gap. Conclusion: Mental and social dimensions of cutaneous leishmaniasis were complex and adversely affected patients' lives by causing psychological burden and limiting their social interactions. Health authorities have to plan programs to increase the disease awareness to prevent the existing stigma to improve patients' social condition and medical care.